Furuise(300228)2024-04-25 08:59Financial Performance - The company's revenue for Q1 2024 was ¥653,563,777.85, a decrease of 14.47% compared to ¥764,176,745.40 in the same period last year[5] - Net profit attributable to shareholders increased significantly by 629.29% to ¥19,805,744.38 from ¥2,715,775.47 year-on-year[5] - Basic earnings per share rose to ¥0.0344, reflecting a 631.91% increase from ¥0.0047 in the same period last year[5] - The net profit for Q1 2024 was CNY 25,732,969.80, a significant increase from CNY 5,039,150.65 in Q1 2023, representing a growth of approximately 411%[27] - The operating profit for the quarter reached CNY 36,661,928.85, compared to CNY 10,846,137.88 in the same period last year, indicating a year-over-year increase of about 238%[27] - The total comprehensive income for Q1 2024 was CNY 25,188,973.14, up from CNY 8,001,979.76 in Q1 2023, reflecting a growth of approximately 214%[28] Cash Flow and Liquidity - The net cash flow from operating activities was negative at -¥98,060,180.36, a decline of 280.21% compared to a positive cash flow of ¥54,414,212.87 in the previous year[13] - Cash flow from operating activities showed a net outflow of CNY -98,060,180.36, contrasting with a net inflow of CNY 54,414,212.87 in Q1 2023[29] - The company reported cash and cash equivalents at the end of the quarter amounting to CNY 365,982,288.47, down from CNY 542,743,162.96 at the end of Q1 2023[31] - Investment activities resulted in a net cash outflow of CNY -10,706,743.10, compared to a net inflow of CNY 78,629,466.32 in the same period last year[31] - Financing activities generated a net cash outflow of CNY -16,625,924.83, compared to a net inflow of CNY 50,719,069.69 in Q1 2023[31] Assets and Liabilities - Total assets increased by 3.70% to ¥4,420,887,797.81 from ¥4,263,054,346.64 at the end of the previous year[5] - Total liabilities increased to CNY 2,350,221,004.05 from CNY 2,237,779,247.97, marking a rise of 5.0%[24] - The company's equity attributable to shareholders rose to CNY 1,935,921,527.26, up from CNY 1,899,175,047.36, an increase of 1.9%[24] Shareholder Information - The total number of common shareholders at the end of the reporting period is 40,237[16] - The largest shareholder, Huang Feng, holds 7.52% of shares, totaling 43,280,000 shares[16] - The top ten shareholders include significant holdings from Morgan Stanley & Co. at 1.72% (9,923,692 shares) and other institutional investors[16] - The total number of restricted shares held by Huang Feng is 32,460,000, which will unlock 25% annually[19] - The company reported a total of 34,650 restricted shares released during the period[19] - The shareholder Wang Chunmei holds 2.84% of shares, totaling 16,369,532 shares, with a portion held through margin trading[17] Research and Development - Research and development expenses increased by 73.92% to ¥20,772,573.03, indicating a focus on innovation and product development[12] - Research and development expenses increased to CNY 20,772,573.03, representing an increase of 73.8% compared to CNY 11,943,564.55 in the previous period[26] Profitability Metrics - The company's gross profit margin improved, contributing to a 238.02% increase in operating profit to ¥36,661,928.85 from ¥10,846,137.88 year-on-year[12] - The company experienced a 155.11% increase in minority interest profit to ¥5,927,225.42, attributed to the profitability of certain subsidiaries[12] Financial Adjustments - The company adjusted its financial derivatives trading limit from RMB 1.3 billion to RMB 800 million, effective for 12 months[20] - The company has not disclosed any related party transactions among the top shareholders[17] - The company has not reported any changes in the top ten shareholders due to securities lending activities[17]